Chemistry:Enbezotinib

From HandWiki
Short description: Chemical compound
Enbezotinib
Enbezotinib structure.png
Identifiers
CAS Number
PubChem CID
Chemical and physical data
FormulaC21H21FN6O3
Molar mass424.436 g·mol−1
3D model (JSmol)

Enbezotinib (TPX-0046) is an experimental anticancer medication which acts as a RET inhibitor, as well as an inhibitor of SRC kinase.[1][2]

See also

References

  1. "The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046". Investigational New Drugs 40 (5): 1133–1136. October 2022. doi:10.1007/s10637-022-01259-x. PMID 35612671. 
  2. "Precious Gene: The Application of RET-Altered Inhibitors". Molecules (Basel, Switzerland) 27 (24): 8839. December 2022. doi:10.3390/molecules27248839. PMID 36557971.